Local Anesthetics — MCQs

Local Anesthetics Indian Medical PG Practice Questions and MCQs

Question 61: What is the common strength of Xylocaine used in dentistry?

A. 2% (Correct Answer)
B. 5%
C. 8%
D. 10%

Explanation: **Explanation:** **Lignocaine (Xylocaine)** is the most widely used local anesthetic in dentistry due to its rapid onset, moderate duration of action, and excellent safety profile. 1. **Why 2% is Correct:** The standard concentration for dental procedures is **2% Lignocaine**. This concentration provides an ideal balance between efficacy and safety. It is typically combined with **Adrenaline (1:80,000 or 1:200,000)** to prolong the duration of anesthesia, provide local hemostasis, and reduce systemic toxicity by slowing absorption. 2. **Why other options are incorrect:** * **5%:** This concentration is generally used for **topical/surface anesthesia** (e.g., Lignocaine ointment) or in specific spinal anesthesia formulations, but it is too toxic for routine dental infiltration or nerve blocks. * **8% & 10%:** These high concentrations are exclusively used as **topical sprays** for mucous membranes (e.g., suppressing the gag reflex during endoscopy or intubation). Injecting such high concentrations into vascular dental tissues would lead to a high risk of Systemic Local Anesthetic Toxicity (LAST). **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Dose:** The maximum dose of plain Lignocaine is **4.5 mg/kg**, while with Adrenaline, it increases to **7 mg/kg**. * **Mechanism:** It works by blocking voltage-gated **sodium (Na+) channels** on the inner surface of the nerve membrane. * **Order of Blockade:** Small myelinated fibers (Autonomic > Pain > Temperature) are blocked before large unmyelinated fibers (Touch > Pressure > Motor). * **Metabolism:** Lignocaine is an **Amide** local anesthetic and is metabolized in the **liver** (unlike Esters, which are metabolized by plasma pseudocholinesterase).

Question 62: What is the drug of choice for ventricular arrhythmias induced by bupivacaine?

A. Bretylium tosylate (Correct Answer)
B. Lidocaine
C. Nifedipine
D. Verapamil

Explanation: **Explanation:** Bupivacaine is a potent, long-acting amide local anesthetic known for its significant **cardiotoxicity**. It binds intensely to voltage-gated sodium channels in the myocardium and dissociates very slowly during diastole (the "fast-in, slow-out" phenomenon). This leads to severe ventricular arrhythmias, including ventricular tachycardia and fibrillation, which are often refractory to standard resuscitation. **Why Bretylium is the Correct Answer:** **Bretylium tosylate** is considered the drug of choice for bupivacaine-induced arrhythmias because it increases the ventricular fibrillation threshold and helps stabilize the cardiac membrane specifically against the re-entrant circuits caused by bupivacaine. It has been shown to be more effective than other anti-arrhythmics in restoring sinus rhythm in this specific toxicological emergency. **Why Other Options are Incorrect:** * **Lidocaine:** This is contraindicated. Since lidocaine is also a local anesthetic that blocks sodium channels, it can exert an **additive toxic effect**, worsening the myocardial depression and conduction block caused by bupivacaine. * **Nifedipine & Verapamil:** These are Calcium Channel Blockers (CCBs). Bupivacaine toxicity already involves the inhibition of calcium signaling; adding CCBs would further depress myocardial contractility and exacerbate heart block or asystole. **High-Yield Clinical Pearls for NEET-PG:** 1. **Intralipid (20% Lipid Emulsion):** In modern clinical practice, **Intravenous Lipid Emulsion (ILE)** is the definitive treatment for Local Anesthetic Systemic Toxicity (LAST). It acts as a "lipid sink," sequestering the lipophilic bupivacaine from the cardiac tissue. 2. **Ropivacaine/Levobupivacaine:** These are S-enantiomers developed to provide similar anesthesia to bupivacaine but with a significantly lower risk of cardiotoxicity. 3. **Avoid Epinephrine:** High doses of epinephrine should be avoided during bupivacaine toxicity as they can worsen arrhythmias.

Question 63: In which of the following conditions is local anesthesia generally ineffective?

A. Edema
B. Localized infection (Correct Answer)
C. Hematoma
D. Anemia

Explanation: **Explanation:** The effectiveness of local anesthetics (LAs) is primarily determined by the pH of the tissue. Local anesthetics are weak bases, usually prepared as hydrochloride salts to maintain stability. **1. Why Localized Infection is the Correct Answer:** In the presence of infection or inflammation, the tissue environment becomes **acidic (low pH)**. According to the Henderson-Hasselbalch equation, an acidic environment shifts the equilibrium of the LA molecule toward its **ionized (charged) form**. Since only the **non-ionized (lipid-soluble) form** can penetrate the neuronal lipid membrane to reach the sodium channels, the onset of anesthesia is delayed or completely blocked. Furthermore, increased vascularity in infected tissues leads to faster systemic absorption, further reducing the local concentration of the drug. **2. Analysis of Incorrect Options:** * **A. Edema:** While edema may dilute the concentration of the anesthetic, it does not fundamentally alter the ionization state of the drug. Anesthesia can still be achieved, though it may require a higher volume. * **C. Hematoma:** A hematoma might physically displace the anesthetic or slightly alter its spread, but it does not cause the significant pH drop seen in infection that renders the drug ineffective. * **D. Anemia:** Anemia affects oxygen-carrying capacity but has no direct pharmacological interaction with the mechanism of action or the ionization of local anesthetics. **3. NEET-PG High-Yield Pearls:** * **Mechanism:** LAs work by blocking **voltage-gated Na+ channels** from the *inside* of the cell membrane. * **pH Dynamics:** To counteract the effect of acidity, **Sodium Bicarbonate** is sometimes added to LAs to increase the non-ionized fraction, thereby speeding up the onset of action and reducing pain on injection. * **Order of Blockade:** Small myelinated fibers (B and A-delta) are blocked before unmyelinated C-fibers. Clinically, **Pain** is lost first, followed by **Temperature, Touch, and Deep Pressure.**

Question 64: Which of the following statements is TRUE regarding dental local anesthetics containing 2% lignocaine with adrenaline 1:80,000?

A. Dental local anesthetics containing 2% lignocaine with adrenaline 1:80,000 may cause tachycardia. (Correct Answer)
B. Dental local anesthetics containing 2% lignocaine with adrenaline 1:80,000 are contraindicated in patients with heart disease in any dosage.
C. Dental local anesthetics containing 2% lignocaine with adrenaline 1:80,000 can produce allergic reactions, in which lignocaine is usually responsible.
D. Dental local anesthetics containing 2% lignocaine with adrenaline 1:80,000 or even prilocaine with felypressin should not be used in the pregnant patient because of the oxytocic effects of adrenaline or felypressin.

Explanation: **Explanation:** **1. Why Option A is Correct:** Adrenaline (Epinephrine) is a potent sympathomimetic amine that acts on both $\alpha$ and $\beta$-adrenergic receptors. Even at the concentration of 1:80,000 used in dental cartridges, systemic absorption can occur. The stimulation of $\beta_1$-receptors in the myocardium leads to positive chronotropic effects, resulting in **tachycardia** and increased cardiac output. This is a common physiological response, especially if the drug is inadvertently injected intravascularly. **2. Why the Other Options are Incorrect:** * **Option B:** Heart disease is **not an absolute contraindication**. While caution is required, the American Heart Association (AHA) suggests that a limited dose (e.g., up to 0.04 mg of adrenaline, roughly 2 cartridges of 1:80,000) is generally safe for patients with stable cardiac conditions. * **Option C:** Lignocaine is an **amide** local anesthetic. True allergic reactions to amides are extremely rare. When an allergy occurs in dental anesthesia, it is usually attributed to the preservative **Methylparaben** or the antioxidant **Sodium Metabisulfite**, rather than the lignocaine itself. * **Option D:** While felypressin (a vasopressin analogue) has theoretical oxytocic effects and is avoided in pregnancy, **adrenaline is not contraindicated**. Adrenaline does not have significant oxytocic properties at dental doses; in fact, $\beta_2$ stimulation can cause uterine relaxation. Lignocaine with adrenaline is considered safe (FDA Category B) for pregnant patients. **High-Yield Clinical Pearls for NEET-PG:** * **Adrenaline Concentrations:** 1:80,000 means 1 gram in 80,000 mL, which equals **12.5 $\mu$g/mL**. * **Maximum Dose:** The max dose of Lignocaine with adrenaline is **7 mg/kg** (up to 500 mg). * **Felypressin:** Often paired with Prilocaine (Citanest); it is a non-catecholamine vasoconstrictor that should be avoided in pregnancy due to potential uterine contraction.

Question 65: Which of the following concentrations of lignocaine can be used?

A. 2%, 5%, 1%
B. 2%, 4%, 5%, 10%
C. 2%, 4%, 5%, 1% (Correct Answer)
D. 2%, 4%, 10%, 1%

Explanation: Lignocaine (Lidocaine) is the most versatile and widely used local anesthetic in clinical practice due to its rapid onset and intermediate duration of action. Its concentration is tailored specifically to the intended route of administration and the desired clinical effect. ### **Explanation of the Correct Answer (C)** Lignocaine is commercially available and clinically utilized in the following concentrations: * **1% and 2%:** These are the standard concentrations used for **Infiltration anesthesia** and **Nerve blocks**. 2% is also commonly used for **Epidural anesthesia**. * **4%:** This concentration is primarily used for **Topical (Surface) anesthesia**, particularly in the airway (e.g., nebulization or spraying for awake intubation) to anesthetize mucous membranes. * **5%:** This is the traditional concentration used for **Spinal anesthesia** (often formulated as "Heavy Lignocaine" with 7.5% dextrose). ### **Analysis of Incorrect Options** * **Option A:** Incorrect because it omits the **4%** concentration, which is a standard preparation for topical airway anesthesia. * **Option B & D:** These include **10%**. While 10% lignocaine spray exists for dental or oropharyngeal use, it is not considered a standard concentration for the broad range of regional techniques (Infiltration, Nerve block, Spinal) typically tested in this context. Option C represents the most classically taught "standard" range in anesthesia textbooks. ### **High-Yield Clinical Pearls for NEET-PG** * **Maximum Dose:** 4 mg/kg (plain) and 7 mg/kg (with adrenaline). * **Mechanism:** Blocks voltage-gated sodium channels from the intracellular side. * **Class:** It is an **Amino-amide** (metabolized in the liver). * **Drug of Choice:** Lignocaine is the DOC for treating **Ventricular Arrhythmias** (Class Ib antiarrhythmic) post-MI. * **Toxicity:** Early signs of LAST (Local Anesthetic Systemic Toxicity) include perioral numbness, metallic taste, and tinnitus.

Question 66: Which of the following local anesthetics is known to cause malignant hyperthermia?

A. Lignocaine (Correct Answer)
B. Prilocaine
C. Bupivacaine
D. Dibucaine

Explanation: **Explanation:** **Malignant Hyperthermia (MH)** is a life-threatening hypermetabolic crisis triggered in genetically susceptible individuals (mutations in the **RYR1 receptor**) primarily by volatile inhalational anesthetics (e.g., Halothane) and the depolarizing muscle relaxant Succinylcholine. **Why Lignocaine is the Correct Answer:** Historically, **Amide-type** local anesthetics, specifically **Lignocaine**, were considered potential triggers for MH based on early animal studies suggesting they could increase calcium release from the sarcoplasmic reticulum. While modern clinical evidence suggests that local anesthetics are generally safe in MH-susceptible patients, for the purpose of standard examinations like NEET-PG, Lignocaine remains the classic "textbook" answer associated with this risk among the options provided. **Analysis of Incorrect Options:** * **B. Prilocaine:** Primarily associated with **Methemoglobinemia** due to its metabolite, o-toluidine. It is not a recognized trigger for MH. * **C. Bupivacaine:** Known for its high **cardiotoxicity** (due to slow dissociation from sodium channels). It is the drug of choice for spinal anesthesia but not linked to MH. * **D. Dibucaine:** An amide anesthetic used to test for **pseudocholinesterase deficiency** (Dibucaine Number). It does not trigger MH. **Clinical Pearls for NEET-PG:** * **Safe Alternatives:** Ester-type local anesthetics (e.g., Procaine) were traditionally considered safer, though currently, all LAs are deemed safe in practice. * **Treatment of Choice:** **Dantrolene** (a hydantoin derivative) which acts by inhibiting the Ryanodine receptor. * **Early Sign:** The earliest sign of MH is an **increase in End-Tidal CO2 (ETCO2)**, followed by tachycardia and muscle rigidity. Hyperthermia is often a late sign.

Question 67: Which of the following conditions is a contraindication to the use of a local anesthetic agent?

A. Parkinson's disease
B. Liver damage
C. Pregnancy (3rd trimester)
D. Hypersensitivity to the drug (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Hypersensitivity to the drug** The only absolute contraindication among the choices is a known **hypersensitivity (allergy)** to the specific local anesthetic (LA) or its chemical class. Allergic reactions are more common with **Esters** (due to the metabolite para-aminobenzoic acid - PABA) than with **Amides**. Anaphylaxis, though rare, can be life-threatening, making hypersensitivity a definitive contraindication. **Analysis of Incorrect Options:** * **A. Parkinson’s Disease:** This is not a contraindication. While clinicians must be cautious with drug interactions (e.g., avoiding epinephrine in patients on COMT inhibitors to prevent hypertensive crises), LAs themselves do not worsen the pathology of Parkinson’s. * **B. Liver Damage:** This is a **relative contraindication/precaution**, not an absolute one. Amide LAs (like Lidocaine and Bupivacaine) are metabolized in the liver. In patients with hepatic failure, the half-life is prolonged, increasing the risk of **Systemic Toxicity (LAST)**. Dosage must be reduced, but the drugs are not strictly forbidden. * **C. Pregnancy (3rd Trimester):** LAs are frequently used for labor analgesia (Epidurals). While pregnancy increases sensitivity to LAs (requiring a dose reduction of ~30% due to engorged epidural veins and hormonal changes), it is not a contraindication. **High-Yield Clinical Pearls for NEET-PG:** * **Classification Trick:** Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne, Pr**i**loca**i**ne), while Esters have only one (Procaine, Benzocaine). * **Maximum Doses:** Lidocaine (4 mg/kg plain; 7 mg/kg with Adrenaline); Bupivacaine (2 mg/kg). * **Drug of Choice for LAST:** Intravenous **20% Lipid Emulsion** is the antidote for Local Anesthetic Systemic Toxicity. * **Prilocaine Side Effect:** Can cause **Methemoglobinemia** (treated with Methylene Blue).

Question 68: Which local anesthetic agent has the highest local tissue irritancy?

A. Procaine
B. Chloroprocaine
C. Lidocaine
D. Bupivacaine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Bupivacaine**. Local tissue irritancy of an anesthetic agent is primarily determined by its chemical structure, concentration, and the presence of preservatives or stabilizers. Among the amide and ester groups, bupivacaine is recognized for having the highest potential for local tissue toxicity and irritancy. **Why Bupivacaine is correct:** Bupivacaine is a long-acting amide local anesthetic. While it is highly valued for its potency and sensory-motor dissociation, it exhibits the highest degree of **myotoxicity** (muscle tissue irritation) and local tissue irritancy compared to other commonly used agents. When injected, it can cause reversible skeletal muscle damage characterized by myofiber degeneration. Additionally, its high lipid solubility and potency contribute to its significant systemic toxicity profile (especially cardiotoxicity). **Why other options are incorrect:** * **Procaine:** An ester-linked anesthetic with low potency and short duration. It is generally non-irritating to tissues but has a high risk of allergic reactions due to its metabolite, PABA (Para-aminobenzoic acid). * **Chloroprocaine:** Known for being the least toxic systemic local anesthetic due to its rapid metabolism by plasma cholinesterase. While older formulations (containing sodium bisulfite) were linked to neurotoxicity, the modern preservative-free version is considered very safe for tissues. * **Lidocaine:** The "gold standard" amide anesthetic. It is significantly less irritating to local tissues than bupivacaine, though it is associated with Transient Neurological Symptoms (TNS) when used in high concentrations for spinal anesthesia. **High-Yield NEET-PG Pearls:** * **Most Cardiotoxic:** Bupivacaine (due to slow dissociation from cardiac sodium channels—"fast in, slow out" kinetics). * **Treatment for Bupivacaine Toxicity:** Intravenous Lipid Emulsion (Intralipid 20%). * **Least Potent/Shortest Acting:** Procaine. * **Safest in Pregnancy:** Lidocaine (Bupivacaine is also used, but Lidocaine has a better safety margin regarding fetal ion trapping).

Question 69: Eutectic lignocaine-prilocaine has which of the following unique properties?

A. It causes motor blockade without sensory block.
B. By surface application, it can anaesthetize unbroken skin. (Correct Answer)
C. It is not absorbed after surface application.
D. It has strong vasoconstrictor action.

Explanation: **Explanation:** **Eutectic Mixture of Local Anesthetics (EMLA)** is a 1:1 oil-in-water emulsion containing 2.5% Lignocaine and 2.5% Prilocaine. **1. Why Option B is Correct:** The term "eutectic" refers to a mixture of two substances that has a **lower melting point** than either of its individual components. While Lignocaine and Prilocaine are solids at room temperature, their mixture becomes a liquid. This unique property allows for a high concentration of the drug to penetrate the **stratum corneum** (the skin's primary barrier). Consequently, EMLA can provide effective topical anesthesia to **intact, unbroken skin**, a feat standard local anesthetics cannot achieve. **2. Why Other Options are Incorrect:** * **Option A:** EMLA provides **sensory blockade** (analgesia), not isolated motor blockade. It is used to numb the skin for procedures like venipuncture or skin grafting. * **Option C:** It **is absorbed** systemically through the skin. Prolonged application or use on large surface areas (especially in infants) can lead to systemic toxicity or methemoglobinemia. * **Option D:** EMLA actually has **biphasic vascular effects**. It typically causes initial vasoconstriction followed by **vasodilation**. It does not possess strong vasoconstrictive properties like cocaine or adrenaline. **High-Yield Clinical Pearls for NEET-PG:** * **Application Time:** Requires **60 minutes** of contact under an occlusive dressing for peak effect (depth of 3-5 mm). * **Contraindication:** Avoid in patients with **Methemoglobinemia** or infants <12 months receiving methemoglobin-inducing drugs (due to the Prilocaine component). * **Usage:** Ideal for pediatric venipuncture, lumbar punctures, and split-thickness skin grafts. * **Warning:** Do not apply to mucous membranes or broken skin, as rapid absorption can lead to **LAST** (Local Anesthetic Systemic Toxicity).

Question 70: Which of the following local anesthetics is most cardiotoxic?

A. Dibucaine
B. Bupivacaine (Correct Answer)
C. Lignocaine
D. Chloroprocaine

Explanation: **Explanation:** **Bupivacaine** is the most cardiotoxic local anesthetic among the commonly used clinical agents. Its high lipid solubility and high affinity for voltage-gated sodium channels in the myocardium lead to a "slow-in, slow-out" phenomenon. Unlike Lignocaine, Bupivacaine dissociates very slowly from cardiac sodium channels during diastole, leading to a cumulative blockade. This results in severe ventricular arrhythmias (like Torsades de Pointes), negative inotropy, and refractory cardiac arrest that is notoriously difficult to resuscitate. **Analysis of Incorrect Options:** * **A. Dibucaine:** While it is a potent amide anesthetic, it is primarily used for its "Dibucaine Number" to identify atypical pseudocholinesterase. It is not the most cardiotoxic in clinical practice. * **C. Lignocaine:** It is the prototype amide anesthetic with a "fast-in, fast-out" profile. It is actually used as an anti-arrhythmic (Class Ib) and has a much higher safety margin regarding cardiac toxicity compared to Bupivacaine. * **D. Chloroprocaine:** An ester-linked anesthetic with a very short half-life due to rapid metabolism by plasma cholinesterases. It has the lowest potential for systemic toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **CC/CNS Ratio:** Bupivacaine has a low ratio (approx. 3.0), meaning the dose required to cause cardiovascular collapse (CC) is close to the dose that causes CNS seizures, leaving a narrow safety margin. * **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for Local Anesthetic Systemic Toxicity (LAST). * **S-Enantiomers:** Levobupivacaine and Ropivacaine were developed as safer alternatives to Bupivacaine, as they exhibit significantly less cardiotoxicity. * **Pregnancy:** Bupivacaine cardiotoxicity is enhanced in pregnancy due to progesterone-induced sensitivity.

Practice by Chapter

Chemistry and Mechanism of Action

Practice Questions

Pharmacokinetics of Local Anesthetics

Practice Questions

Amide Local Anesthetics

Practice Questions

Ester Local Anesthetics

Practice Questions

Clinical Uses of Local Anesthetics

Practice Questions

Toxicity of Local Anesthetics

Practice Questions

Management of Local Anesthetic Systemic Toxicity

Practice Questions

Adjuvants to Local Anesthetics

Practice Questions

Maximum Safe Doses

Practice Questions

Local Anesthetics in Special Populations

Practice Questions

Allergic Reactions to Local Anesthetics

Practice Questions

Future Developments in Local Anesthetics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free